Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 700 | 310 | 200 | 420 | 200 |
| Gross Profit | 700 | 310 | 200 | 420 | 200 |
| Operating Expenses | 13,320 | 6,920 | 6,950 | 4,600 | 3,320 |
| Operating Income | -12,620 | -6,610 | -6,750 | -4,180 | -3,120 |
| Other Income | -330 | -1,900 | 0 | 0 | 600 |
| Pre-tax Income | -12,950 | -8,510 | -6,750 | -4,180 | -2,520 |
| Income Tax | 0 | 30 | -660 | -200 | -80 |
| Net Income Continuous | -12,990 | -6,150 | -3,882 | -3,988 | -2,440 |
| Net Income | $-12,950 | $-8,540 | $-6,090 | $-3,980 | $-2,430 |
| EPS Basic Total Ops | -4.27 | -2.37 | -1.80 | -2.09 | N/A |
| EPS Basic Continuous Ops | -4.28 | -2.39 | -1.81 | -2.08 | N/A |
| EPS Diluted Total Ops | -4.27 | -2.37 | -1.80 | -2.09 | N/A |
| EPS Diluted Continuous Ops | -4.28 | -2.39 | -1.81 | -2.08 | N/A |
| EBITDA(a) | $-11,870 | $-5,950 | $-6,180 | $-3,880 | $-2,990 |